<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02704299</url>
  </required_header>
  <id_info>
    <org_study_id>CBMG-TCM-GC-1.1</org_study_id>
    <nct_id>NCT02704299</nct_id>
  </id_info>
  <brief_title>The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.</brief_title>
  <official_title>A Single-centered Clinical Trial of Surgery，Chemotherapy in Combination With Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cellular Biomedicine Group Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Cancer Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cellular Biomedicine Group Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the feasibility ,safety and efficacy of Surgery，Chemotherapy in Combination with
      Autologous T cells-Based Immunotherapy for Advanced Gastric Cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Safety:AE/SAE Efficacy:immunologic function;FPS
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression-Free-Survival(PFS)</measure>
    <time_frame>24months</time_frame>
    <description>The primary objective is to assess progression free survival (PFS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidences of adverse events or serious adverse events</measure>
    <time_frame>24months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Gastric Cancer.</condition>
  <arm_group>
    <arm_group_label>Autologous T cells-Based Immunotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Surgery Chemotherapy Autologous T cells-Based Immunotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Autologous T cells-Based Immunotherapy</intervention_name>
    <description>TCM cells are the subpopulation of T lymphocytes with key characteristics including high potency and long-term memory of specific immunity.</description>
    <arm_group_label>Autologous T cells-Based Immunotherapy</arm_group_label>
    <other_name>TCM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 18 to 80 years, males and females.

          -  Subjects who understand and sign the consent form for this study.

          -  The pathologically confirmed advanced gastric cancer T3、T4 or T2 and Metastasis in
             lymph nodes.

          -  Subjects are surgical candidates.

          -  No distant metastasis (M0) and No distant lymph node metastasis.

          -  Expected survival time of at least 6 months.

        Exclusion Criteria:

          -  Subjects who do not sign the consent form for this study.

          -  The subject has an allergic history of medicine or food.

          -  The subject has uncontrolled or hard-to-control diseases of
             cardiovascular,liver,kidney or lung,endocrine system.

          -  The subject tests positive for: HIV, hepatitis virus, syphilis or other infectious
             diseases.

          -  The subject has an history of other malignant tumour.

          -  The subject has history of alcoholism, drug abuse, or mental illness in the 12 years
             prior to this trial.

          -  The subject has participated in any other clinical trial in the 3 months prior to this
             trial.

          -  The subject is pregnant, lactating or planning to conceive within the next 24 months.

          -  The subject has any other unsuitable or adverse condition to be determined by the
             investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>/ / /, /</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <overall_contact>
    <last_name>Jiafu / Ji, Doctor</last_name>
  </overall_contact>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>March 9, 2016</last_update_submitted>
  <last_update_submitted_qc>March 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

